Archives

by in
Entry Author Date Location
Constellation Pharmaceuticals Garners $5,000,000 New Financing 08/05/14 Boston
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Epizyme Prices IPO at $15 Per Share, Begins Trading Friday 05/30/13 Boston
Meet Ben Fidler, Xconomy’s New East Coast Biotech Editor 04/15/13 New York
Third Rock Stocks Up With $516M New Fund, Looks to Start 16 Cos 03/25/13 Boston
Third Rock’s Bet on Lotus Tissue Repair Generates Big Return 02/27/13 Boston
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
See What GSK, J&J, KPCB, Third Rock & Orbimed Have in Common Oct. 16 10/03/12 San Francisco
Boston Scientific, Foundation, GnuBio, & More in Boston Life Sciences News 09/21/12 Boston
Seventh Sense, Polaris, & More Boston Life Sciences Newsmakers 06/15/12 Boston
Global Blood Therapeutics, Third Rock’s First West Coast Startup, Gets $41M 06/14/12 San Francisco
Genentech, Roche Find New Balance Three Years Post-Merger 05/29/12 San Francisco
Option to Buy: The New Face of Biotech Funding? 02/13/12 National
Flagship, Joule, Constellation, and More of The Week’s Boston Dealmakers 01/18/12 Boston
Genentech Pours $95M Into Constellation’s Drug Platform 01/17/12 Boston
Constellation Pharma Raises More Money and Further Defines Pipeline 06/17/11 Boston
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News 06/10/11 Boston
General Compression Pulls In $20.4M, Constellation Nabs $15M, PolyRemedy Wraps Up $20M, & More Boston-Area Deals News 06/08/11 Boston
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S. 06/07/11 National
Constellation Pharma Raises $15M for Epigenetic Drugs 06/06/11 Boston
Constellation Pharmaceuticals Garners $15,000,000 Series B Funding 06/06/11 Boston
Tom Maniatis, Molecular Biology Pioneer, Seeks to Help Build a Kendall Square in NYC 04/05/11 New York
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41 02/10/11 Boston
Shots from the Front Row of Boston’s War on Cancer Event 10/22/10 Boston
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News 10/15/10 Boston
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer 10/14/10 Boston
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D 10/05/10 Boston
MIT Cancer Research Star Tyler Jacks Takes Closing Keynote Role at Xconomy Forum 09/28/10 Boston
What Is Boston Doing for the War on Cancer? Find Out at Xconomy Forum on October 20 08/25/10 Boston
Page 1 of 2 next page »